Patterns of ecstasy use and associated harm: Results of a Brazilian online survey

Substance Use and Misuse

Volumn 44, Issue 14, 2009, Pages 2014-2027

  De Almeida, Stella Pereira ^a   Garcia Mijares, Miriam ^a   Silva, Maria Teresa Araujo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug abuse prevention; Ecstasy; Harm reduction; Internet; MDMA; Psychotropic drugs; Web survey

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; DISEASE ASSOCIATION; DRUG ABUSE PATTERN; DRUG DEPENDENCE; FEMALE; HARM REDUCTION; HEALTH SURVEY; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HUMAN; INTERNET; MALE; MULTIPLE DRUG ABUSE; ONLINE SYSTEM; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RISK ASSESSMENT; SEX DIFFERENCE; SEXUAL ORIENTATION; SOCIAL CLASS; UNSAFE SEX;

ADOLESCENT; ADULT; AGE FACTORS; BRAZIL; FEMALE; HARM REDUCTION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; INTERNET; MALE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RISK FACTORS; RISK-TAKING; SELF ADMINISTRATION; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; UNSAFE SEX;

EID: 72949110144     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826080902848566     Document Type: Article

References (57)

1. Allott, K., Redman, J. (2006). Patterns of use and harm reduction practices of ecstasy users in Australia. Drug and Alcohol Dependence, 82(2):168-176.
2. Almeida, S. P., Silva, M. T. A. (2003). Ecstasy (MDMA): Effects and patterns of use reported by users in São Paulo. Revista Brasileira de Psiquiatria, 25(1):11-17.
3. Almeida, S. P., Silva, M. T. (2005). Characteristics of ecstasy users in Sao Paulo, Brazil. Substance Use and Misuse, 40(3):395-404.
4. Almeida, P. M.,Wickerhauser, H. (1991). O Critério ABA/ABIPEME - em Busca de Uma Atualização [ABA/ABIPEME criterion-searching for an update]. São Paulo, Brazil: ABA/ABIPEME.
5. Baggott, M. J. (2002). Preventing problems in Ecstasy users: Reduce use to reduce harm. Journal of Psychoactive Drugs, 34(2):145-162.
6. Banta-Green, C., Goldbaum, G., Kingston, S., Golden, M., Harruff, R., Logan, B. K. (2005). Epidemiology of MDMA and associated club drugs in the Seattle area. Substance Use and Misuse, 40(9-10):1295-1315.
7. Barrett, S. P., Gross, S. R., Garand, I., Pihl, R. O. (2005). Patterns of simultaneous polysubstance use in Canadian rave attendees. Substance Use and Misuse, 40(9-10):1525-1537.
8. Battisti, M. C., Noto, A. R., Nappo, S., Carlini, E. A. (2006). A profile of Ecstasy (MDMA) use in Sao Paulo, Brazil: An ethnographic study. Journal of Psychoactive Drugs, 38(1):13-18.
9. Beamish, P. W. (2006). Publishing international (joint venture) research for impact. Asia Pacific Journal of Management, 23:29-46.
10. Bellis, M. A., Hughes, K., Bennett, A., Thomson, R. (2003). The role of an international nightlife resort in the proliferation of recreational drugs. Addiction, 98(12):1713-1721.
11. Britt, G. C., McCance-Katz, E. F. (2005). A brief overview of the clinical pharmacology of "club drugs." Substance Use and Misuse, 40(9-10):1189-1201.
12. Carlini, E. A., Galduŕoz, J. C. F., Noto, A. R., Nappo, S. A. (2002). Primeiro levantamento domiciliar sobre o uso de drogas psicotŕopicas no Brasil [First household survey on the use of psychotropic drugs in Brazil]. São Paulo, Brazil: Secretaria Nacional Antidrogas.
13. Caruso, M. (2005). A nova era do ecstasy - Popularização da "droga das raves" leva a grandes apreensões e a novos estudos [The new age of ecstasy - Popularization of the "drug of raves" lead to great apprehension rates and new studies]. Revista Isto É, 1853:53-55.
14. CETIC, Centro de Estudos sobre as Tecnologias da Informação e da Comunicação.(2006). Pesquisa sobre o uso das Tecnologias da Informação e da Comunicação no Brasil [Survey on the use of information and communication technologies in Brazil]. São Paulo, Brazil: Comitê Gestor da Internet no Brasil.
15. Chinet, L., Stephan, P., Zobel, F., Halfon, O. (2007). Party drug use in techno nights: A field survey among French-speaking Swiss attendees. Pharmacology Biochemistry and Behavior, 86(2):284-289.
16. Copeland, J., Dillon, P., Gascoigne, M. (2006). Ecstasy and the concomitant use of pharmaceuticals. Addictive Behaviors, 31(2):367-370.
17. Cottler, L. B., Womack, S. B., Compton, W. M., Ben-Abdallah, A. (2001). Ecstasy abuse and dependence among adolescents and young adults: Applicability and reliability of DSM-IV criteria. Human Psychopharmacology, 16(8):599-606.
18. de Almeida, M. I. M., Eugenio, F. (2005). Ćapsulas ḿagicas da balada perfeita - jovens e ecstasy no Rio de Janeiro [Magical capsules of perfect party-youth and ecstasy in Rio de Janeiro]. Revista Insight Inteligência, 29:52-62.
19. Degenhardt, L., Barker, B., Topp, L. (2004). Patterns of ecstasy use in Australia: Findings from a national household survey. Addiction, 99(2):187-195.
20. El-Mallakh, R. S., Abraham, H. D. (2007). MDMA (Ecstasy). Ann Clin Psychiatry, 19(1):45-52.
21. Fendrich, M., Johnson, T. P. (2005). Editors' introduction to this special issue on club drug epidemiology. Substance Use and Misuse, 40(9-10):1179-1184.
22. Foreman, D. M., Foreman, D., Minty, E. B. (2005). The association between hyperkinesis and breakdown of parenting in clinic populations. Archives of Disease in Childhood, 90(3):245-248.
23. Gamma, A., Jerome, L., Liechti, M. E., Sumnall, H. R. (2005). Is ecstasy perceived to be safe? A critical survey. Drug Alcohol Depend, 77(2):185-193.
24. Goldenberg, V. (2002). Ranking the correlates of psychotherapy duration. Administration and Policy in Mental Health, 29(3):201-214.
25. Gouzoulis-Mayfrank, E., Daumann, J. (2006). The confounding problem of polydrug use in recreational ecstasy/MDMA users: A brief overview. Journal of Psychopharmacology, 20(2):188-193.
26. Green, A. R., Sanchez, V., O'Shea, E., Saadat, K. S., Elliott, J. M., Colado, M. I. (2004). Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Psychopharmacology, 173(3-4):264-269.
27. Gunter, T. D., Arndt, S., Wenman, G. (2006). Characteristics of admissions for primary stimulant dependence during 2001. Substance Use and Misuse, 41(9):1277-1286.
28. IBGE, Instituto Brasileiro de Geografia e Estatística.(2005). Acesso ̀a Internet e posse de telefone ḿovel celular para uso pessoal [Internet acess and ownership of cellular mobile telephone for personal use]. Rio de Janeiro, Brazil: Instituto Brasileiro de Geografia e Estatística.
29. Jager, G., de Win, M. M., Vervaeke, H. K., Schilt, T., Kahn, R. S., van den Brink, W., et al. (2007). Incidental use of ecstasy: No evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology, 193(3):403-414.
30. Kinner, S. A., Degenhardt, L. (2006). Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia. Drug and Alcohol Review, 25(5):445-449.
31. Lee, S. J., Galanter, M., Dermatis, H., McDowell, D. (2003). Circuit parties and patterns of drug use in a subset of gay men. Journal of Addictive Diseases, 22(4):47-60.
32. Levy, K. B., O'Grady, K. E.,Wish, E. D., Arria, A. M. (2005). An in-depth qualitative examination of the ecstasy experience: Results of a focus group with ecstasy-using college students. Substance Use and Misuse, 40(9-10):1427-1441.
33. Logan, B. K., Couper, F. J. (2001). 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. Journal of Forensic Sciences, 46(6):1426-1433.
34. Lyvers, M. (2006). Recreational ecstasy use and the neurotoxic potential of MDMA: Current status of the controversy and methodological issues. Drug and Alcohol Review, 25(3):269-276.
35. Maxwell, J. C. (2005). Party drugs: Properties, prevalence, patterns, and problems. Substance Use and Misuse, 40(9-10):1203-1240.
36. McCaughan, J. A., Carlson, R. G., Falck, R. S., Siegal, H. A. (2005). From "Candy Kids" to "Chemi- Kids": A typology of young adults who attend raves in the midwestern United States. Substance Use and Misuse, 40(9-10):1503-1523.
37. McElrath, K. (2005). MDMA and sexual behavior: Ecstasy users' perceptions about sexuality and sexual risk. Substance Use and Misuse, 40(9-10):1461-1477.
38. Meulman, J. J. (1998). Optimal scaling methods for multivariate categorical data analysis. SPSS white paper, Laiden University, The Netherlands.
39. Nature Editorial. (2004). Think harder about ecstasy. Nature, 429(6988):113.
40. NIDA. (2002). Conference reviews advances in prevention science, announces new national research initiative. NIDA Notes, 16(6):1-4.
41. Nutt, D. J. (2006). A tale of two Es. Journal of Psychopharmacology, 20(3):315-317.
42. Parrott, A. C. (2005). Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. Journal of Psychopharmacology, 19(1):71-83.
43. Parrott, A. C. (2006). MDMA in humans: Factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. Journal of Psychopharmacology, 20(2):147-163.
44. Pentney, A. R. (2001). An exploration of the history and controversies surrounding MDMA and MDA. Journal of Psychoactive Drugs, 33(3):213-221.
45. Pluddemann, A., Parry, C. D., Myers, B., Bhana, A. (2004). Ecstasy use in South Africa: Findings from the South African Community Epidemiology Network on Drug Use (SACENDU) project (January 1997-December 2001). Substance Use and Misuse, 39(1):87-105.
46. Quadrello, T., Hurme, H., Menzinger, J., Smith, P. K., Veisson, M., Vidal, S., et al. (2005). Grandparents use of new communication technologies in a European perspective. European Journal of Ageing, 2:200-207.
47. Schifano, F. (2004). A bitter pill. Overview of ecstasy (MDMA,MDA) related fatalities. Psychopharmacology, 173(3-4):242-248.
48. Scholey, A. B., Parrott, A. C., Buchanan, T., Heffernan, T. M., Ling, J., Rodgers, J. (2004). Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A www study. Addictive Behaviors, 29(4):743-752.
49. Silveira, A. C. (2005). Investimento em tecnologia e inteligência policial resultam em apreensões recordes doDENARC [Investment in technology and police intelligence lead to record apprehensions by DENARC]. http://www.policia-civ.sp.gov.br/denarc/dnc news20050630.htm (accessed February 2007).
50. Theall, K. P., Elifson, K.W., Sterk, C. E. (2006). Sex, touch, and HIV risk among ecstasy users. AIDS and Behavior, 10(2):169-178.
51. Topp, L., Hando, J., Dillon, P., Roche, A., Solowij, N. (1999). Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence, 55(1-2):105-115.
52. Tossmann, P., Boldt, S., Tensil, M. D. (2001). The use of drugs within the techno party scene in European metropolitan cities. European Addiction Research, 7(1):2-23.
53. UNODC. (2006a). World drug report (1) (p. 142). New York, NY: United Nations - Office on Drug and Crimes.http://www.unodc.org/unodc/world drug report.html (accessed February 2007).
54. UNODC. (2006b). World drug report (1), (p. 152). New York, NY: United Nations - Office on Drug and Crimes. http://www.unodc.org/unodc/world drug report.html (accessed February 2007).
55. von Sydow, K., Lieb, R., Pfister, H., Hofler, M., Wittchen, H. U. (2002). Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study. Drug and Alcohol Dependence, 66(2):147-159.
56. Weir, E. (2000). Raves: A review of the culture, the drugs and the prevention of harm. Canadian Medical Association Journal, 162(13):1843-1848.
57. White, B., Degenhardt, L., Breen, C., Bruno, R., Newman, J., Proudfoot, P. (2006). Risk and benefit perceptions of party drug use. Addictive Behaviors, 31(1):137-142.